ATLANTA, GA - December 15, 2025 ( NEWMEDIAWIRE) - GeoVax Labs, Inc. (Nasdaq: GOVX), a clinical-stage biotechnology company developing multi-antigen vaccines and immunotherapies, today announced the ...
Canadian Patent No. 3043594, entitled “Method of Using Human Mesenchymal Stem Cells to Effect Cellular and Humoral Immunity,” provides Longeveron with patent rights in Canada through 2037.
A new study analyzing the immune response to COVID-19 in a Catalan cohort of health workers sheds light on an important ...
Immune cells called B cells make antibodies that fight off invading bacteria, viruses and other foreign substances. During ...
In hepatitis B virus (HBV) infection, the capacity to mount a functional virus-specific T-cell response has long been considered the principal, if not the sole, immunological determinant of viral ...
Plants form a critical model for understanding regulated cell death (RCD) as part of their sophisticated immune responses. In the ongoing evolutionary arms ...
Cellular access is faster than Wi-Fi at most US airports. A full 70% of US airport Wi-Fi networks still use Wi-Fi 5. Run a speed test at your local airport to see which is faster. Here's a common ...
Antigen-driven TCR signaling in the epidermis during CD8+ TRM differentiation results in a lower TGFβ requirement for persistence and increased proliferative capacity that together enhance epidermal ...
As winter sets in, food choices often shift toward ingredients linked with immunity support to prevent any infections or illnesses - quite a common scenario in the colder months. Sweet potatoes, ...
CD8⁺ T cells are central effectors of antitumor immunity, capable of recognizing and eliminating malignant cells. Their presence within tumors often ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback